Orlando, FL -- (SBWIRE) -- 09/13/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR), Macy's, Inc.(NYSE:M).
Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) shares gained 4.18% to $4.99. The company on Sept 6 announced that it has entered into a settlement agreement with Wockhardt USA, LLC and Wockhardt Ltd. (collectively, "Wockhardt") to resolve pending patent litigation in response to Wockhardt's abbreviated new drug application (ANDA) seeking approval to market generic versions of Avanir's NUEDEXTA® (dextromethorphan hydrobromide/quinidine sulfate) capsules. The settlement agreement grants Wockhardt the right to begin selling a generic version of NUEDEXTA on July 30, 2026, or earlier under certain circumstances.
Additionally, the company announced that on September 3, 2013, the Company approved the grant of stock options to new employees to purchase a total of 69,600 shares of common stock in the aggregate. The stock options were granted as inducements material to the new employees entering into employment with Avanir, as permitted under NASDAQ Listing Rule 5635(c)(4).
Are investors worried about the recent updates with AVNR? Find out with a free trend analysis HERE
Macy's, Inc.(NYSE:M) shares dropped 1.38% to $43.53. The company on Sept. 9 announced an effort to grow its market share in active wear and to strengthen its appeal to the Millennial customer with an expansion of its athletic apparel assortment, which will include Nike®, The North Face, Under Armour®, Calvin Klein Performance™ and Ideology®, to more stores this fall and the addition of Helly Hansen® in select locations. This aggressive expansion of active follows the retailer's announcement of its relationship with Finish Line last fall, as well as with team sport experts, LIDS, announced last month.
Additionally, the company on Sept. 3 announced the pricing of the public offering of $400.0 million aggregate principal amount of senior notes due 2023 by its wholly owned subsidiary, Macy's Retail Holdings, Inc. The senior notes were issued at a price of 99.314% of par and will bear interest at a rate of 4.375% per annum. The senior notes will be fully and unconditionally guaranteed on a senior unsecured basis by Macy's, Inc. The transaction is expected to close on or about September 6, 2013.
Is M going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Disclosure: HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)